Are Korean Biopharma Alliances Recovering After Gloomy Year?
Trend Toward Higher Upfronts
Recent sizable out-licensing deals with global big pharma firms are raising hopes of a recovery in Korean biopharma alliances and also point to possible changes in deal structures towards international norms.
